Patients who are using any form of compounded semaglutide should consult with their healthcare provider about transitioning to FDA-approved options now that the compounded options are being phased out, she says
Chang G, Liu J, Qin S, Jiang Y, Zhang P, Yu H, Lu K, Zhang N, Cao L, Wang Y
Food interactions Information not available
Novo Nordisk has also cited indirect comparison data suggesting that fewer patients discontinued oral semaglutide due to side effects compared with orforglipron, though the companies and independent commentators note the significant methodological limitations of such comparisons in the absence of a head-to-head obesity trial
Many people actually prefer this since injecting room-temperature medication feels more comfortable than cold medication